Christine Lu

Journal article

The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines

Subsidised access to high-cost medicines in Australia is restricted under national programs (the Pharmaceutical Benefits Scheme, PBS, and the Repatriation Pharmaceutical Benefits Scheme, RPBS) with a view to achieving cost-effective use. The aim of this study was to examine the use and associated government cost...